A.G. de Boer

2.3k citations

40 papers · 1.9k indexed · h-index 23

Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems 9
- Drug Solubulity and Delivery Systems 4
Neurology top 5%
- Barrier Structure and Function Studies 7
Molecular Medicine top 5%
Biomaterials top 5%
Surfaces, Coatings and Films top 10%
Oncology
- Drug Transport and Resistance Mechanisms 13
Cellular and Molecular Neuroscience
- Neuroscience and Neuropharmacology Research 4
Psychiatry and Mental health
- Epilepsy research and treatment 4
Pediatrics, Perinatology and Child Health
- Pharmacological Effects and Toxicity Studies 4
Food Science
- Salmonella and Campylobacter epidemiology 3

Co-authors: D. D. Breimer Hans E. Junginger Awie F. Kotzé H.L. Lueßen J. Coos Verhoef Maya Thanou Meindert Danhof Margret C.M. Blom-Roosemalen
Cited by: Pharmaceutical Science Neurology Molecular Medicine
Journals: Brain Research (1 paper)Journal of Controlled Release (6 papers)Journal of Neurochemistry (1 paper)
Partner nations: Netherlands South Africa United Kingdom

In The Last Decade

A.G. de Boer

40 papers receiving 1.8k citations

Peers

Countries citing papers authored by A.G. de Boer

Since Specialization

Citations

This map shows the geographic impact of A.G. de Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.G. de Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.G. de Boer more than expected).

Fields of papers citing papers by A.G. de Boer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.G. de Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.G. de Boer. The network helps show where A.G. de Boer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A.G. de Boer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A.G. de Boer Line = papers co-authored together A.G. de Boer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comparative population structure analysis of Campylobacter jejuni from human and poultry origin in Bangladesh European Journal of Clinical Microbiology & Infectious Diseases ·Zhahirul Islam,Alex van Belkum,Jaap A. Wagenaar,Alison J. Cody,A.G. de Boer,S. K. Sarker,Bart C. Jacobs,Kaisar A. Talukder,Hubert P. Endtz	2014	12
2	Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood–brain barrier AIDS ·Inez C. J. van der Sandt,Catharina M.P. Vos,Lobna Nabulsi,Margret C.M. Blom-Roosemalen,Heleen H. Voorwinden,A.G. de Boer,D. D. Breimer	2001	97
3	Enhancement of paracellular drug transport with highly quaternized N‐trimethyl chitosan chloride in neutral environments: In vitro evaluation in intestinal epithelial cells (Caco‐2) Journal of Pharmaceutical Sciences ·Awie F. Kotzé,Maya Thanou,H.L. Lueβen,A.G. de Boer,J. Coos Verhoef,Hans E. Junginger	1999	128
4	Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration Behavioural Pharmacology ·M.B. Hesselink,H. Smolders,A.G. de Boer,D. D. Breimer,Wojciech Danysz	1999	22
5	Chitosan for enhanced intestinal permeability: Prospects for derivatives soluble in neutral and basic environments European Journal of Pharmaceutical Sciences ·Awie F. Kotzé,H.L. Lueßen,A.G. de Boer,J. Coos Verhoef,Hans E. Junginger	1999	156
6	The Role of Probenecid-Sensitive Organic Acid Transport in the Pharmacokinetics of N-Methyl-d-Aspartate Receptor Antagonists Acting at the GlycineB-Site: Microdialysis and Maximum Electroshock Seizures Studies Journal of Pharmacology and Experimental Therapeutics ·M.B. Hesselink,H. Smolders,Bernd Eilbacher,A.G. de Boer,D. D. Breimer,Wojciech Danysz	1999	19
7	Chapter 20 Cytokines and blood-brain barrier permeability Progress in brain research ·A.G. de Boer,D. D. Breimer	1998	34
8	Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayers International Journal of Pharmaceutics ·Awie F. Kotzé,Bas J. de Leeuw,H.L. Lueßen,A.G. de Boer,J. Coos Verhoef,Hans E. Junginger	1997	115
9	The Use of Intracerebral Microdialysis for the Determination of Pharmacokinetic Profiles of Anticancer Drugs in Tumor-Bearing Rat Brain Pharmaceutical Research ·Elizabeth C. M. de Lange,J. D. de Vries,C. Zurcher,Meindert Danhof,A.G. de Boer,D. D. Breimer	1995	33
10	Eicosanoid production by rat cerebral endothelial cells: Stimulation by lipopolysaccharide, interleukin-1 and interleukin-6 Journal of Neuroimmunology ·Helga E. de Vries,Karin H. Hoogendoorn,Jeanette Van Dijk,Freek J. Zijlstra,Anne‐Marie van Dam,D. D. Breimer,Theo J.C. van Berkel,A.G. de Boer,Johan Kuiper	1995	55
11	High-density lipoprotein and cerebral endothelial cells in vitro: Interactions and transport Biochemical Pharmacology ·Helga E. de Vries,B. Breedveld,Johan Kuiper,A.G. de Boer,Th.J.C. van Berkel,D. D. Breimer	1995	30
12	Quantification and Visualization of the Transport of Octreotide, a Somatostatin Analogue, Across Monolayers of Cerebrovascular Endothelial Cells Pharmaceutical Research ·Ulrich Jaehde,Rosalinde Masereeuw,A.G. de Boer,Gert Fricker,J. Fred Nagelkerke,Jacky Vonderscher,D. D. Breimer	1994	30
13	Effect of anisotonic conditions on the transport of hydrophilic model compounds across monolayers of human colonic cell lines. Journal of Pharmacology and Experimental Therapeutics ·A.B.J. Noach,Munetoshi Sakai,Margret C.M. Blom-Roosemalen,Hugo R. de Jonge,A.G. de Boer,D. D. Breimer	1994	19
14	Absorption enhancement of hydrophilic compounds by verapamil in Caco-2 cell monolayers Biochemical Pharmacology ·Michinori Sakai,A.B.J. Noach,Margret C.M. Blom-Roosemalen,A.G. de Boer,D.D. Breimer	1994	17
15	Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy. Journal of Pharmacology and Experimental Therapeutics ·M A Hurni,A.B.J. Noach,Margret C.M. Blom-Roosemalen,A.G. de Boer,J. Fred Nagelkerke,D. D. Breimer	1993	74
16	Characterization of the Scavenger Receptor on Bovine Cerebral Endothelial Cells In Vitro Journal of Neurochemistry ·Helga E. de Vries,Johan Kuiper,A.G. de Boer,Th.J.C. van Berkel,D. D. Breimer	1993	22
17	In vitro penetration of des-tyrosine1-D-phenylalanine3-β-casomorphin across the blood-brain barrier Peptides ·Holger Stark,Joost B. M. M. van Bree,A.G. de Boer,Ulrich Jaehde,D.D. Breimer	1992	3
18	Drug transport across the blood — brain barrier Pharmacy World & Science ·Joost B. M. M. van Bree,A.G. de Boer,Meindert Danhof,D. D. Breimer	1992	17
19	The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into the central nervous system Journal of Pharmacokinetics and Biopharmaceutics ·Joost B. M. M. van Bree,Anne V. Baljet,Anton van Geyt,A.G. de Boer,Meindert Danhof,Douwe D. Breimer	1989	31
20	Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. Journal of Pharmacology and Experimental Therapeutics ·J. B. Bree,A.G. de Boer,Meindert Danhof,L.A. Ginsel,D. D. Breimer	1988	121

About A.G. de Boer

A.G. de Boer is a scholar working on Pharmaceutical Science, Neurology and Oncology, having authored 40 papers that have together received 1.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (13 papers), Advanced Drug Delivery Systems (9 papers), Barrier Structure and Function Studies (7 papers), Neuroscience and Neuropharmacology Research (4 papers), Drug Solubulity and Delivery Systems (4 papers), Epilepsy research and treatment (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Salmonella and Campylobacter epidemiology (3 papers). The work is most often cited by research in Pharmaceutical Science (799 citations), Neurology (196 citations) and Molecular Medicine (97 citations). A.G. de Boer has collaborated with scholars based in Netherlands, South Africa and United Kingdom. Frequent co-authors include D. D. Breimer, Hans E. Junginger, Awie F. Kotzé, H.L. Lueßen, J. Coos Verhoef, J. Coos Verhoef, Maya Thanou, Meindert Danhof, Margret C.M. Blom-Roosemalen and Claus‐Michael Lehr. Their work appears in journals such as Brain Research, Journal of Controlled Release and Journal of Neurochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact